| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386)
|
Marchetti, Claudia
|
|
2015
|
94 |
3 |
p. 302-310
9 p.
|
artikel
|
| 2 |
Bevacizumab: A dose review
|
Falk, Alexander T.
|
|
2015
|
94 |
3 |
p. 311-322
12 p.
|
artikel
|
| 3 |
Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials
|
Qi, Wei-Xiang
|
|
2015
|
94 |
3 |
p. 323-336
14 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2015
|
94 |
3 |
p. IFC-
1 p.
|
artikel
|
| 5 |
Heterogeneity of hepatocellular carcinoma contributes to cancer progression
|
Jeng, Kuo-Shyang
|
|
2015
|
94 |
3 |
p. 337-347
11 p.
|
artikel
|
| 6 |
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature
|
De Bari, Berardino
|
|
2015
|
94 |
3 |
p. 360-370
11 p.
|
artikel
|
| 7 |
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology
|
Brandes, Alba A.
|
|
2015
|
94 |
3 |
p. 348-359
12 p.
|
artikel
|
| 8 |
Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy
|
Spano, Jean-Philippe
|
|
2015
|
94 |
3 |
p. 270-278
9 p.
|
artikel
|
| 9 |
Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer
|
Fedele, Palma
|
|
2015
|
94 |
3 |
p. 291-301
11 p.
|
artikel
|
| 10 |
Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review with meta-analysis
|
Nunes, Altacílio Aparecido
|
|
2015
|
94 |
3 |
p. 261-269
9 p.
|
artikel
|
| 11 |
Trabectedin: Supportive care strategies and safety profile
|
Jordan, Karin
|
|
2015
|
94 |
3 |
p. 279-290
12 p.
|
artikel
|
| 12 |
Whole pelvic intensity-modulated radiotherapy for gynecological malignancies: A review of the literature
|
Hymel, Rockne
|
|
2015
|
94 |
3 |
p. 371-379
9 p.
|
artikel
|
Tijdschrift beschrijving